Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Zacharowski

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Der Anaesthesist|March 17, 2007
[New reflections on inflammation and coagulation]K Zacharowski
Der Anaesthesist|October 1, 2020
[FX06-COVID: Improvement of arterial oxygenation in intensive care patients with a severe course of COVID-19]K Zacharowski,
Pharmacology & Therapeutics|August 5, 2000
Selective activation of E-type prostanoid(3)-receptors reduces myocardial infarct size. A novel insight into the cardioprotective effects of prostaglandinsC Thiemermann, K Zacharowski
British Journal of Anaesthesia|April 24, 2016
Mild anaemia indeed requires treatmentD R Spahn, K Zacharowski
British Journal of Anaesthesia|April 17, 2015
Non-treatment of preoperative anaemia is substandard clinical practiceD R Spahn, K Zacharowski
European Journal of Pharmacology|May 4, 2001
Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the ratK Zacharowski, B Blackburn, C Thiemermann
Der Anaesthesist|September 20, 2015
[Comments on: Conserved blood is not conserved blood?]S Choorapoikayil, K Zacharowski, P Meybohm
European Journal of Pharmacology|March 19, 1999
Reduction of myocardial injury by the EP3 receptor agonist TEI-3356. Role of protein kinase C and of K(ATP)-channelsK Zacharowski, A Olbrich, C Thiemermann
Thrombosis Research|July 30, 2020
A comprehensive assessment of the coagulation profile in critically ill COVID-19 patientsE H Adam, K Zacharowski, W Miesbach
Der Anaesthesist|September 26, 2018
[Knowledge of German anesthetists on antibiotic stewardship]H Mutlak, K Zacharowski, C Ernst, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Der Anaesthesist|March 17, 2007
[New reflections on inflammation and coagulation]K Zacharowski
Der Anaesthesist|October 1, 2020
[FX06-COVID: Improvement of arterial oxygenation in intensive care patients with a severe course of COVID-19]K Zacharowski,
Pharmacology & Therapeutics|August 5, 2000
Selective activation of E-type prostanoid(3)-receptors reduces myocardial infarct size. A novel insight into the cardioprotective effects of prostaglandinsC Thiemermann, K Zacharowski
British Journal of Anaesthesia|April 24, 2016
Mild anaemia indeed requires treatmentD R Spahn, K Zacharowski
British Journal of Anaesthesia|April 17, 2015
Non-treatment of preoperative anaemia is substandard clinical practiceD R Spahn, K Zacharowski
European Journal of Pharmacology|May 4, 2001
Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the ratK Zacharowski, B Blackburn, C Thiemermann
Der Anaesthesist|September 20, 2015
[Comments on: Conserved blood is not conserved blood?]S Choorapoikayil, K Zacharowski, P Meybohm
European Journal of Pharmacology|March 19, 1999
Reduction of myocardial injury by the EP3 receptor agonist TEI-3356. Role of protein kinase C and of K(ATP)-channelsK Zacharowski, A Olbrich, C Thiemermann
Thrombosis Research|July 30, 2020
A comprehensive assessment of the coagulation profile in critically ill COVID-19 patientsE H Adam, K Zacharowski, W Miesbach
Der Anaesthesist|September 26, 2018
[Knowledge of German anesthetists on antibiotic stewardship]H Mutlak, K Zacharowski, C Ernst, et al.
Pageof 10